Published in Int J Clin Pharmacol Ther on December 01, 1997
Capillaroscopy and the measurement of capillary pressure. Br J Clin Pharmacol (2000) 1.05
Treatment of essential hypertension does not normalize capillary rarefaction. Clinics (Sao Paulo) (2008) 0.82
Different toxic effects of ouabain and 16-epi-gitoxin on Purkinje fibres and ventricular muscle fibres. Pharmacology (1976) 0.84
Interindividual differences in the pharmacokinetics of digitoxin and digoxin during long-term treatment. Eur J Clin Pharmacol (1981) 0.83
Digitalis. Pharmacol Ther (1982) 0.81
Comparison of therapeutic and toxic actions of ouabain, gitoxin and 16-epi-gitoxin on isolated atria at different extracellular potassium concentrations. Eur J Pharmacol (1973) 0.81
Different relationships between therapeutic and toxic actions of 16-epi-gitoxin, gitoxin and ouabain on isolated cardiac preparations. Eur J Pharmacol (1970) 0.80
[On the intestinal effect of digitoxin, penta-acetylgitoxin and other acetylgitoxins]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1966) 0.77
Studies on the metabolic pattern of propiverine in urine after single administration. Pharmazie (1988) 0.77
[Effect of synthetic antifibrinolytics on allergic reactions]. Dermatol Wochenschr (1967) 0.76
Cardiotoxicity of digitalis. Arch Toxicol Suppl (1986) 0.76
Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations. Acta Biol Med Ger (1975) 0.76
[Studies on pharmacological modification of the localized Sanarelli-Shwartzman phenomenon]. Folia Haematol Int Mag Klin Morphol Blutforsch (1972) 0.75
On the cardiac efficacy of helveticosol-3',4'-di-nitrate, a new glycoside. Arch Int Pharmacodyn Ther (1979) 0.75
[The diagnostic value of the aminophenazone breath test in chronic liver diseases]. Z Gesamte Inn Med (1991) 0.75
[Studies on the release of vasoactive substances during the process of coagulation and fibrinolysis in human blood]. Acta Biol Med Ger (1965) 0.75
Elimination of 16-acetyl-gitoxin in patients suffering from impaired liver function. Int J Clin Pharmacol Ther Toxicol (1987) 0.75
The effect of pentaerithrityl-tetranitrate on parameters of the microcirculation. Int J Clin Pharmacol Ther (1998) 0.75
Cardiac effects of 16-acetyl-gitoxin, the active glycoside after penta-acetyl-gitoxin administration. Acta Biol Med Ger (1978) 0.75
Pharmacokinetic investigations in man of two acetyl derivatives of 16alpha-gitoxin. Eur J Clin Pharmacol (1977) 0.75
[Bioavailability of etilefrine from Thomasin and Thomasin sustained-release tablets]. Pharmazie (1985) 0.75
[Measurment of contractility of the isolated heart using a BM 101 Biometer with an additional differentiating unit]. Acta Biol Med Ger (1974) 0.75
[Animal experimental studies on the effect of a protease inhibitor from the bovine lung]. Acta Biol Med Ger (1966) 0.75
Investigation into the species-specific deacylation of penta-acetyl-gitoxin. Eur J Clin Pharmacol (1978) 0.75
Pharmacokinetic investigations with 3H-penta-acetyl-gitoxin in volunteers and patients with respect to the occurrence of drug latentiation. Int J Clin Pharmacol Biopharm (1978) 0.75
[Value of the 14C-aminophenazone inhalation test: inhibition of the demethylation function of the liver by cimetidine]. Z Gesamte Inn Med (1986) 0.75
Studies on cardioactive steroids. II. Structure-activity relationships in the isolated guinea-pig heart. Pharmacology (1974) 0.75
Extraordinary cardiac effects of 16-epi-gitoxin in comparison to ouabain in cats and dogs. Pharmacology (1977) 0.75
[Clinico-pharmacological and clinical evaluation of pengitoxin]. Farmakol Toksikol (1982) 0.75
[Dangers of rapid digitalization]. Z Gesamte Inn Med (1979) 0.75
On the specificity of the aminophenazone breath test. Int J Clin Pharmacol Ther Toxicol (1986) 0.75
[Clinical pharmacology of cardiac glycosides]. Pol Tyg Lek (1978) 0.75
On the pharmacokinetics of pengitoxin and its cardioactive derivative 16-acetyl-gitoxin. Eur J Clin Pharmacol (1983) 0.75
Interaction between phenprocoumon and phytomenadion: a pharmacokinetic investigation in healthy volunteers. Biomed Biochim Acta (1984) 0.75
Uptake and liberation of [3H]16-acetyl-gitoxin in the isolated guinea pig atrium. Biomed Biochim Acta (1987) 0.75
Bioequivalence of tolbutamide-containing tablet preparations. Int J Clin Pharmacol Ther (1997) 0.75
Individualization of drug dosage during long-term treatment with phenprocoumon (Falithrom). Int J Clin Pharmacol Biopharm (1978) 0.75
Studies on cardioactive steroids. V. Structure-activity relationships of derivatives of 16 alpha-gitoxin. Pharmacology (1980) 0.75
On the pharmacokinetics of talinolol, a new beta 1-receptor blocking agent. Int J Clin Pharmacol Ther Toxicol (1981) 0.75
Problems of an optimum digitalis therapy. Int J Clin Pharmacol Ther Toxicol (1980) 0.75
[Quantitative thin-layer chromatographic estimation of aminophenazone (I.N.N.), 4-methylaminophenazone and 4-aminophenazone in plasma (author's transl)]. Pharmazie (1981) 0.75
Kinetic properties of 3H-16alpha-gitoxin in the isolated guinea-pig atrium. Acta Biol Med Ger (1978) 0.75
[Clinical pharmacology of semisynthetic penicillins and cephalosporins]. Z Arztl Fortbild (Jena) (1977) 0.75
On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent. Int J Clin Pharmacol Biopharm (1979) 0.75
A simple method for routine determination of the metabolic liver capacity: the aminopyrine breath test. Int J Clin Pharmacol Ther Toxicol (1985) 0.75
[Methods for determination of cardiac glycosides--possibilities and experiences]. Z Med Lab Diagn (1979) 0.75
Studies on cardioactive steroids. IV. Influence of nitrate ester formation on cardiac and extracardiac activity. Pharmacology (1980) 0.75
On the pharmacokinetics of 16-acetyl-gitoxin and its bioavailability from pengitoxin-containing tablet formulations. J Pharmacokinet Biopharm (1986) 0.75
[Interaction of digoxin and quinidine]. Z Gesamte Inn Med (1980) 0.75
[Animal experimental tests of the prothrombin synthesis inhibition effect of coumarin derivatives]. Acta Biol Med Ger (1966) 0.75
Differences in color vision impairment caused by digoxin, digitoxin, or pengitoxin. J Cardiovasc Pharmacol (1982) 0.75
[Acute beta blocker poisoning]. Z Gesamte Inn Med (1985) 0.75
Determination of N-butyl-scopolamine bromide in human plasma and urine by a HPLC method. Evidence of negligible absorption after oral administration. Pharmazie (1993) 0.75
Cost-benefit analysis--a prerequisite of a rational pharmacotherapy in cardiovascular diseases. Timely thrombolysis in the acute myocardial infarction. Int J Clin Pharmacol Ther (1996) 0.75
[Studies on diagnostic and prognostic validity of aminophenazone breath test in liver cirrhosis]. Gastroenterol J (1991) 0.75
Measurement of plasma glycoside level following pengitoxin administration. Eur J Clin Pharmacol (1978) 0.75
Studies on cardioactive steroids. I. Structure-activity relationships on the isolated atrium. Pharmacology (1974) 0.75
Dose-dependent shortening of systolic time intervals after intake of pengitoxin. Int J Clin Pharmacol Res (1987) 0.75
Bioequivalence of allopurinol-containing tablet preparations. Int J Clin Pharmacol Ther (1999) 0.75
On the relations between serotonin uptake and function of the transport-ATPase system of blood platelets. Acta Biol Med Ger (1973) 0.75
[Influence of exogenous factors on the behavior of aminophenazone breath test in chronic liver diseases]. Gastroenterol J (1991) 0.75
[Behavior of the aminophenazone breath test in chronic liver diseases]. Z Gesamte Inn Med (1988) 0.75
Structure-activity relationship of natural and semi-synthetic genins and glycosides as investigated on the smooth muscle of the guinea-pig ileum. Pharmacology (1973) 0.75
Therapeutic range of cardiac glycosides. Basic Res Cardiol (1984) 0.75
Problems of rapid digitalization in severe congestive heart failure. Eur J Cardiol (1980) 0.75
The 14C-aminophenazone breath test in pesticide workers. Int Arch Occup Environ Health (1986) 0.75
The determination of aminopyrin elimination for control of the metabolic capacity of the liver in man. Eur J Clin Invest (1982) 0.75
Absorption and metabolism in man of 16-epi-gitoxin, a new semi-synthetic cardioactive glycoside. Eur J Clin Pharmacol (1977) 0.75
[Hepatic clearance of aminopyrine in the evaluation of liver function in hormonal contraception]. Z Gesamte Inn Med (1983) 0.75
Binding of 16alpha-gitoxin and its 16-acetate to human serum albumin. Eur J Clin Pharmacol (1977) 0.75
On the plasma protein binding of 16-acetyl-gitoxin. Int J Clin Pharmacol Ther Toxicol (1981) 0.75